A detailed history of Confluence Investment Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Confluence Investment Management LLC holds 1,190,994 shares of GILD stock, worth $112 Million. This represents 1.4% of its overall portfolio holdings.

Number of Shares
1,190,994
Previous 1,202,728 0.98%
Holding current value
$112 Million
Previous $82.5 Million 20.98%
% of portfolio
1.4%
Previous 1.24%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$66.59 - $83.99 $781,367 - $985,538
-11,734 Reduced 0.98%
1,190,994 $99.8 Million
Q2 2024

Jul 01, 2024

SELL
$63.15 - $72.88 $2.73 Million - $3.15 Million
-43,266 Reduced 3.47%
1,202,728 $82.5 Million
Q1 2024

Apr 01, 2024

SELL
$71.58 - $87.29 $3.57 Million - $4.35 Million
-49,883 Reduced 3.85%
1,245,994 $91.3 Million
Q4 2023

Nov 05, 2024

BUY
$73.27 - $83.09 $5.57 Million - $6.31 Million
75,960 Added 6.38%
1,266,954 $103 Million
Q3 2023

Oct 10, 2023

SELL
$73.94 - $80.67 $933,492 - $1.02 Million
-12,625 Reduced 0.96%
1,295,877 $97.1 Million
Q2 2023

Jul 03, 2023

SELL
$76.01 - $86.7 $1.62 Million - $1.85 Million
-21,352 Reduced 1.61%
1,308,502 $101 Million
Q1 2023

Apr 04, 2023

SELL
$77.31 - $88.08 $1.25 Million - $1.42 Million
-16,143 Reduced 1.2%
1,329,854 $110 Million
Q4 2022

Jan 03, 2023

BUY
$62.32 - $89.47 $369,121 - $529,930
5,923 Added 0.44%
1,345,997 $116 Million
Q3 2022

Oct 03, 2022

BUY
$59.54 - $68.01 $1.81 Million - $2.06 Million
30,363 Added 2.32%
1,340,074 $82.7 Million
Q2 2022

Jul 12, 2022

BUY
$57.72 - $65.01 $1.88 Million - $2.12 Million
32,554 Added 2.55%
1,309,711 $81 Million
Q1 2022

Apr 04, 2022

BUY
$57.92 - $72.58 $2.18 Million - $2.74 Million
37,722 Added 3.04%
1,277,157 $75.9 Million
Q4 2021

Jan 04, 2022

BUY
$64.88 - $73.64 $969,047 - $1.1 Million
14,936 Added 1.22%
1,239,435 $90 Million
Q3 2021

Oct 04, 2021

BUY
$67.69 - $73.03 $723,199 - $780,252
10,684 Added 0.88%
1,224,499 $85.5 Million
Q2 2021

Jul 01, 2021

BUY
$63.47 - $69.35 $1.46 Million - $1.59 Million
22,986 Added 1.93%
1,213,815 $83.6 Million
Q1 2021

Apr 05, 2021

BUY
$60.0 - $68.46 $5 Million - $5.7 Million
83,280 Added 7.52%
1,190,829 $77 Million
Q4 2020

Jan 25, 2021

SELL
$56.65 - $64.55 $5.68 Million - $6.47 Million
-100,269 Reduced 8.3%
1,107,549 $64.5 Million
Q3 2020

Oct 19, 2020

SELL
$62.1 - $78.08 $2.45 Million - $3.08 Million
-39,440 Reduced 3.16%
1,207,818 $76.3 Million
Q2 2020

Jul 01, 2020

SELL
$72.34 - $84.0 $2.92 Million - $3.39 Million
-40,406 Reduced 3.14%
1,247,258 $96 Million
Q1 2020

Jun 03, 2020

BUY
$62.63 - $80.22 $198,599 - $254,377
3,171 Added 0.25%
1,287,664 $96.3 Million
Q1 2020

Apr 08, 2020

BUY
$62.63 - $80.22 $4.72 Million - $6.05 Million
75,441 Added 6.24%
1,284,493 $96 Million
Q4 2019

Jun 02, 2020

SELL
$61.62 - $67.78 $2.04 Million - $2.24 Million
-33,110 Reduced 2.67%
1,209,052 $81.7 Million
Q4 2019

Jan 29, 2020

BUY
$61.62 - $67.78 $383,584 - $421,930
6,225 Added 0.5%
1,242,162 $80.7 Million
Q3 2019

Oct 15, 2019

BUY
$62.51 - $69.0 $1.68 Million - $1.86 Million
26,885 Added 2.22%
1,235,937 $78.3 Million
Q2 2019

Jul 24, 2019

BUY
$61.87 - $69.38 $612,018 - $686,306
9,892 Added 0.82%
1,209,052 $81.7 Million
Q1 2019

Apr 16, 2019

BUY
$62.53 - $70.05 $2.32 Million - $2.6 Million
37,167 Added 3.2%
1,199,160 $78 Million
Q4 2018

Jan 04, 2019

SELL
$60.54 - $79.0 $1.81 Million - $2.37 Million
-29,940 Reduced 2.51%
1,161,993 $72.7 Million
Q3 2018

Oct 25, 2018

SELL
$71.28 - $78.92 $1.81 Million - $2 Million
-25,336 Reduced 2.08%
1,191,933 $92 Million
Q2 2018

Jul 12, 2018

BUY
$64.88 - $75.68 $27.9 Million - $32.6 Million
430,540 Added 54.73%
1,217,269 $86.2 Million
Q1 2018

Apr 04, 2018

BUY
$72.84 - $88.8 $57.3 Million - $69.9 Million
786,729 New
786,729 $59.3 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Confluence Investment Management LLC Portfolio

Follow Confluence Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Confluence Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Confluence Investment Management LLC with notifications on news.